Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

BUY
$0.6 - $12.6 $14,536 - $305,272
24,228 Added 3.2%
782,372 $493,000
Q1 2022

May 06, 2022

BUY
$1.09 - $1.53 $99,254 - $139,320
91,059 Added 13.65%
758,144 $910,000
Q4 2021

Feb 04, 2022

BUY
$1.38 - $1.74 $276,000 - $348,000
200,000 Added 42.82%
667,085 $1 Million
Q2 2021

Aug 03, 2021

BUY
$1.69 - $2.85 $85,346 - $143,927
50,501 Added 12.12%
467,085 $808,000
Q1 2021

May 12, 2021

BUY
$1.81 - $3.88 $45,250 - $97,000
25,000 Added 6.38%
416,584 $1.1 Million
Q2 2020

Aug 04, 2020

BUY
$1.16 - $2.61 $240,498 - $541,120
207,326 Added 112.52%
391,584 $853,000
Q1 2020

May 05, 2020

BUY
$1.06 - $2.16 $15,470 - $31,525
14,595 Added 8.6%
184,258 $267,000
Q4 2019

Feb 05, 2020

BUY
$1.69 - $2.16 $286,730 - $366,472
169,663 New
169,663 $297,000

About Akari Therapeutics Plc


  • Ticker AKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,349,200
  • Market Cap $123M
  • Description
  • Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...
More about AKTX
Track This Portfolio

Track Omnia Family Wealth, LLC Portfolio

Follow Omnia Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omnia Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omnia Family Wealth, LLC with notifications on news.